Johnson & Johnson’s McNeil Consumer Healthcare division has announced that it has officially resumed the shipment of Tylenol Cold & Flu Severe caplets, a product which had previously been recalled due to manufacturing deficiencies. In a timely and smart move, the company positioned its resumption of shipping activities to coincide with the upcoming cold and flu season.
Since September 2009, J&J has announced more than two dozen recalls, which involved more than 300 million bottles of nonprescription medications, as well as some prescription drugs, contact lenses, defective blood glucose test strips and artificial hips. The pharmaceutical giant has clearly been plagued by faulty products over the past few years, many of which have damaged the company’s once stellar reputation. In fact, due to the excessive recalls of popular J&J brands like Tylenol, Motrin and Benadryl, the company’s sales fell by almost $900 million last year alone.
